Literature DB >> 31188625

Ensuring Effective Utilization of Biospecimens: Design, Marketing, and Other Important Approaches.

Marianna J Bledsoe1, Katherine C Sexton2.   

Abstract

A number of studies have shown that underutilization of biospecimens from bioresources (biobanks and biorepositories) is a significant concern. In addition, biospecimen underutilization has been identified as an ethical as well as practical concern. The utilization of biospecimens is affected by many factors, including the establishment of a scientific need for the biospecimens, the design of the bioresource, strategic planning, biospecimen quality and fitness for purpose, informed consent considerations, access policies and procedures, and marketing. This article discusses the impact of these factors on biospecimen utilization and provides suggestions for how bioresources can optimize biospecimen utilization from their collections.

Keywords:  ELSI issues; biobank; biorepository; biospecimen; marketing; utilization

Mesh:

Year:  2019        PMID: 31188625      PMCID: PMC6588104          DOI: 10.1089/bio.2019.0007

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  21 in total

1.  Biobanking 3.0: evidence based and customer focused biobanking.

Authors:  Daniel Simeon-Dubach; Peter Watson
Journal:  Clin Biochem       Date:  2014-01-06       Impact factor: 3.281

2.  Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.

Authors:  Alison Parry-Jones
Journal:  Biopreserv Biobank       Date:  2014-12       Impact factor: 2.300

Review 3.  From patients to partners: participant-centric initiatives in biomedical research.

Authors:  Jane Kaye; Liam Curren; Nick Anderson; Kelly Edwards; Stephanie M Fullerton; Nadja Kanellopoulou; David Lund; Daniel G MacArthur; Deborah Mascalzoni; James Shepherd; Patrick L Taylor; Sharon F Terry; Stefan F Winter
Journal:  Nat Rev Genet       Date:  2012-04-03       Impact factor: 53.242

4.  A framework for biobank sustainability.

Authors:  Peter H Watson; Sara Y Nussbeck; Candace Carter; Sheila O'Donoghue; Stefanie Cheah; Lise A M Matzke; Rebecca O Barnes; John Bartlett; Jane Carpenter; William E Grizzle; Randal N Johnston; Anne-Marie Mes-Masson; Leigh Murphy; Katherine Sexton; Lois Shepherd; Daniel Simeon-Dubach; Nikolajs Zeps; Brent Schacter
Journal:  Biopreserv Biobank       Date:  2014-02       Impact factor: 2.300

5.  Individual investigator profiles of biospecimen use in cancer research.

Authors:  Lauren Braun; Maria Lesperance; Anne-Marie Mes-Massons; Ming S Tsao; Peter H Watson
Journal:  Biopreserv Biobank       Date:  2014-06-11       Impact factor: 2.300

6.  Underutilization of specimens in biobanks: an ethical as well as a practical concern?

Authors:  R Jean Cadigan; Eric Juengst; Arlene Davis; Gail Henderson
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

7.  Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA).

Authors:  Elena Bravo; Alessia Calzolari; Paola De Castro; Laurence Mabile; Federica Napolitani; Anna Maria Rossi; Anne Cambon-Thomsen
Journal:  BMC Med       Date:  2015-02-17       Impact factor: 8.775

8.  Neglected ethical issues in biobank management: Results from a U.S. study.

Authors:  R Jean Cadigan; Dragana Lassiter; Kaaren Haldeman; Ian Conlon; Erik Reavely; Gail E Henderson
Journal:  Life Sci Soc Policy       Date:  2013-12-01

9.  Quantifying the use of bioresources for promoting their sharing in scientific research.

Authors:  Laurence Mabile; Raymond Dalgleish; Gudmundur A Thorisson; Mylène Deschênes; Robert Hewitt; Jane Carpenter; Elena Bravo; Mirella Filocamo; Pierre Antoine Gourraud; Jennifer R Harris; Paul Hofman; Francine Kauffmann; Maria Angeles Muñoz-Fernàndez; Markus Pasterk; Anne Cambon-Thomsen
Journal:  Gigascience       Date:  2013-05-01       Impact factor: 6.524

10.  Characterizing biobank organizations in the U.S.: results from a national survey.

Authors:  Gail E Henderson; R Jean Cadigan; Teresa P Edwards; Ian Conlon; Anders G Nelson; James P Evans; Arlene M Davis; Catherine Zimmer; Bryan J Weiner
Journal:  Genome Med       Date:  2013-01-25       Impact factor: 11.117

View more
  8 in total

1.  The Utilization of Biospecimens: Impact of the Choice of Biobanking Model.

Authors:  William E Grizzle; Marianna J Bledsoe; Sameer Al Diffalha; Dennis Otali; Katherine C Sexton
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

Review 2.  Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2020-10-08       Impact factor: 2.300

3.  The Importance of Human Tissue Bioresources in Advancing Biomedical Research.

Authors:  Sameer Al Diffalha; Katherine C Sexton; Peter H Watson; William E Grizzle
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

4.  The Future of Biobanking: What Is Next?

Authors:  Luciana Caenazzo; Pamela Tozzo
Journal:  BioTech (Basel)       Date:  2020-11-23

5.  Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability.

Authors:  Carmel M Quinn; Mamta Porwal; Nicola S Meagher; Anusha Hettiaratchi; Carl Power; Jitendra Jonnaggadala; Sue McCullough; Stephanie Macmillan; Katrina Tang; Winston Liauw; David Goldstein; Nikolajs Zeps; Philip J Crowe
Journal:  Biomark Insights       Date:  2021-03-27

Review 6.  The Availability of Human Biospecimens to Support Biomarker Research.

Authors:  Tamsin E Tarling; Jennifer A Byrne; Peter H Watson
Journal:  Biomark Insights       Date:  2022-04-19

7.  The Skeleton in the Closet: Faults and Strengths of Public Versus Private Genetic Biobanks.

Authors:  Pamela Tozzo; Luciana Caenazzo
Journal:  Biomolecules       Date:  2020-09-03

8.  Analysis of Biospecimen Demand and Utilization of Samples from the National Amyotrophic Lateral Sclerosis Biorepository.

Authors:  Marianna J Bledsoe; Lindsay Rechtman; Laurie Wagner; Paul Mehta; D Kevin Horton; Wendy E Kaye
Journal:  Biopreserv Biobank       Date:  2021-07-14       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.